
Pharmacy Benefits and Disease-Modifying Therapies
Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.